70 results
6-K
EX-10.1
BLRX
BioLineRx Ltd.
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s
20-F/A
2023 FY
BLRX
BioLineRx Ltd.
26 Mar 24
Annual report (foreign) (amended)
4:57pm
development, while Accelerated Approval and Priority Review relate to the marketing approval stage.
European Union/European Economic Area
Clinical … Trials
Within the European Union (EU) and the European Economic Area (EEA), which is composed of the 27 member states of the EU plus Norway, Iceland
6-K
EX-99
BLRX
BioLineRx Ltd.
30 Aug 23
Current report (foreign)
6:45am
in a Material Adverse Effect. To the Company’s knowledge, none of the Company’s or its Subsidiaries’ employees is a member of a union that relates … (including without limitation the U.S. Department of the Treasury’s Office of Foreign Asset Control), the United Kingdom, the European Union or any other
6-K
EX-99
BLRX
BioLineRx Ltd.
30 Aug 23
Current report (foreign)
6:45am
applicable sanctions, export control, and anti-boycott laws and regulations of the United States, the European Union, the United Kingdom, and any other … , the designation as a “specially designated national” or “blocked person”), the United Nations Security Council (“UNSC”), the European Union, the United
6-K
EX-10.1
z99r83m2 gnqzn3
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.1
vfo 4r9rc7
3 Sep 21
Current report (foreign)
4:30pm
6-K
EX-99
4bidsc
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
w8roz 9b24puvo3sl3su
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
ixqmv9vzujweb6
19 Jan 21
Prospectus supplement for primary offering
5:00pm
6-K
EX-10.1
m9tjj5cnub lxsa
25 Sep 20
Current report (foreign)
4:33pm
6-K
EX-99
hbvnx
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
lmo9qt70
28 May 20
Current report (foreign)
11:56am